| |
Headline |
Date
|
| |
Gilead now testing ritonavir replacement in human studies
|
23.07.08 |
| |
Nucleoside levels in seminal fluid higher than in blood, but not inside cells
|
18.06.08 |
| |
Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
|
13.05.08 |
| |
BHIVA: Concerns over confidentiality, drug interactions, communication, barriers to integrating GPs into HIV care
|
02.05.08 |
| |
Unexpected drug interaction found between Kaletra and rosuvastatin
|
17.04.08 |
| |
CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients
|
06.02.08 |
| |
Kaletra monotherapy studies yield conflicting results
|
28.01.08 |
| |
Etravirine (TMC125, Intelence) granted accelerated approval in US
|
21.01.08 |
| |
Interaction between efavirenz and phenytoin can result in undetectable blood levels of efavirenz
|
03.01.08 |
| |
Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment
|
19.11.07 |
| |
EACS: Once-a-day Kaletra can be risky
|
29.10.07 |
| |
ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir
|
21.09.07 |
| |
ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance
|
19.09.07 |
| |
IAS: Studies present reassuring data on the use of ART in patients on TB treatment
|
23.07.07 |
| |
IAS: Botswanan study finds low concentrations of TB drugs common in HIV-positives, predict TB treatment failure
|
23.07.07 |
| |
Pfizer advises maraviroc dose increase if combined with etravirine
|
20.07.07 |
| |
Study suggests many children could have subtherapeutic levels of efavirenz
|
06.06.07 |
| |
CROI: Therapeutic concentrations of efavirenz, Kaletra, could be difficult to achieve in some children, with or without rifampicin
|
07.03.07 |
| |
Severe interaction between low-dose ritonavir and a blood pressure drug observed
|
12.12.06 |
| |
Merck buys protease inhibitor from Ambrilia, may be potent booster of other PIs
|
20.10.06 |
